Utah Medical Products Inc (NASDAQ: UTMD) is a medical device company that designs, manufactures, and sells specialty devices for obstetrics, gynecology, urology, and biopharma applications. Revenue comes from direct product sales to hospitals and clinicians, with a portion moving through national Med/Surg distributors, plus a small royalty income stream. UTMD operates with its own direct sales force and customer service staff across the U.S., Canada, Ireland, France, the UK, New Zealand, and Australia, supplemented by independent consultants and manufacturer representatives. The company is headquartered in Midvale, Utah, with primary manufacturing in Utah and Athlone, Ireland. UTMD has grown through acquisitions, including Columbia Medical (1997), Gesco (1998), Abcorp (2004), and Femcare (2011). Sales to Med/Surg distributors comprised 15% of total domestic direct sales in FY2025, with the remainder sold direct. Royalty income was $20 in FY2025. UTMD trades on the NASDAQ Global Market and owns most of its facilities outright.

Revenue model

Transactional product sales of medical devices to hospitals, clinicians, and OEM customers, with Med/Surg distributor sales representing 15% of domestic direct sales in FY2025. A small royalty income stream exists from licensing proprietary technology to third parties ($20 thousand in FY2025). UTMD also pays royalties on certain third-party technology incorporated into its products ($164 thousand in cost of goods sold in FY2025).

Products and services

UTMD's product portfolio spans obstetrics, gynecology, urology, and biopharma devices. Gynecology and urology products include the Filshie clip system (female sterilization, acquired via Femcare), the Add-a-Cath suprapubic catheter introducer, the Supra-Foley suprapubic catheterization procedure kit, and the Liberty System for conservative treatment of female urinary incontinence via electrical stimulation. Additional product lines originate from the Columbia Medical, Gesco, and Abcorp acquisitions.

Customers and end markets

Primary customers are hospitals and clinicians in obstetrics, gynecology, and urology. In the U.S., hospital customers may route purchases through national Med/Surg distributors. Group purchasing organizations (GPOs) act as bargaining agents for member hospitals. End markets include labor and delivery units, gynecology surgical suites, urology departments, and biopharma device users. UTMD notes that long-term GPO supply agreements can restrict access to certain hospital customers.

Value-chain role

UTMD is a vertically integrated medical device manufacturer. It designs and manufactures products primarily at its Utah and Ireland facilities, holds proprietary IP, licenses technology to third parties, and sells through its own direct sales force as well as select distributors and independent representatives. The company acquires third-party technology via licensing or acquisition when it can be combined with UTMD proprietary product concepts.

Geographic exposure

Operations as of early 2026 span Midvale, Utah (105,000 sq ft), Athlone, Ireland (77,000 sq ft), Romsey, England (38,600 sq ft), Castle Hill, Australia (3,200 sq ft), and Mississauga, Canada (4,700 sq ft). Sales presence covers the U.S., Canada, Ireland, France, the UK, New Zealand, and Australia. Manufacturing is concentrated in Utah and Ireland.

Source: SEC 10-K, filed 2026-03-27

Industry: Surgical & Medical Instruments & Apparatus Peers: Bioventus Inc Rxsight Inc CERUS CORP Sanara Medtech Inc OraSure Technologies Inc Pulmonx Corp SmileDirectClub, Inc. TELA Bio Inc UFP Technologies Inc